{
    "title": "IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY",
    "abstract": "IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY William D. Travis Sanja Dacic Ignacio Wistuba Lynette Sholl Prasad Adusumilli Lukas Bubendorf Paul Bunn Tina Cascone Jamie Chaft Gang Chen Teh-Ying Chou Wendy Cooper Jeremy J. Erasmus Carlos Gil Ferreira Jin-Mo Goo John Heymach Fred R. Hirsch Hidehito Horinouchi Keith Kerr Mark Kris Deepali Jain Young T. Kim Fernando Lopez-Rios Shun Lu Tetsuya Mitsudomi Andre Moreira Noriko Motoi Andrew G. Nicholson Ricardo Oliveira Mauro Papotti Ugo Pastorino Luis Paz-Ares Giuseppe Pelosi Claudia Poleri Mariano Provencio Anja C. Roden Giorgio Scagliotti Stephen G. Swisher Erik Thunnissen Ming S. Tsao Johan Vansteenkiste Walter Weder Yasushi Yatabe",
    "authors": [
        "William D. Travis",
        "Sanja Dacic",
        "Ignacio Wistuba",
        "Lynette Sholl",
        "Prasad Adusumilli",
        "Lukas Bubendorf",
        "Paul Bunn",
        "Tina Cascone",
        "Jamie Chaft",
        "Gang Chen",
        "Teh-Ying Chou",
        "Wendy Cooper",
        "Jeremy J. Erasmus",
        "Carlos Gil Ferreira",
        "Jin-Mo Goo",
        "John Heymach",
        "Fred R. Hirsch",
        "Hidehito Horinouchi",
        "Keith Kerr",
        "Mark Kris",
        "Deepali Jain",
        "Young T. Kim",
        "Fernando Lopez-Rios",
        "Shun Lu",
        "Tetsuya Mitsudomi",
        "Andre Moreira",
        "Noriko Motoi",
        "Andrew G. Nicholson",
        "Ricardo Oliveira",
        "Mauro Papotti",
        "Ugo Pastorino",
        "Luis Paz-Ares",
        "Giuseppe Pelosi",
        "Claudia Poleri",
        "Mariano Provencio",
        "Anja C. Roden",
        "Giorgio Scagliotti",
        "Stephen G. Swisher",
        "Erik Thunnissen",
        "Ming S. Tsao",
        "Johan Vansteenkiste",
        "Walter Weder",
        "Yasushi Yatabe"
    ],
    "published_year": "Not available",
    "description": "",
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173999/",
    "doi": "https://doi.org/10.1016/j.jtho.2020.01.005",
    "citation_count": 116,
    "references": {
        "11020048": "Easily applicable predictive score for MPR based on parameters before neoadjuvant chemoimmunotherapy in operable NSCLC: a single-center, ambispective, observational study",
        "11010993": "An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy",
        "10996281": "Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy",
        "10951859": "Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective",
        "10948551": "Current challenges and practical aspects of molecular pathology for non-small cell lung cancers",
        "10926577": "Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy",
        "10924307": "Case report: Pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy",
        "10878980": "Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial",
        "10841500": "Pathologic processing of lung cancer resection specimens after neoadjuvant therapy",
        "10803255": "Association between pathologic response and survival after neoadjuvant therapy in lung cancer",
        "10794016": "Management of locally advanced non\u2010small cell lung cancer: State of the art and future directions",
        "10792477": "Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non\u2013Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial",
        "10742991": "Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process",
        "10710239": "A Comparison of the Preclinical Performance of the Echelon\u2122+ Stapler with Thunderbird Reloads to Two Commercial Endoscopic Surgical Staplers",
        "10660168": "Efficacy of neoadjuvant therapy for lung squamous cell carcinoma and lung adenocarcinoma: A retrospective comparative study",
        "10651418": "Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Chemotherapy versus Chemotherapy Alone in Non-Small Cell Lung Cancer: A Propensity Score and Inverse Probability Treatment Weighting Analysis",
        "10646649": "Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery",
        "10636541": "Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations",
        "10636463": "Neoadjuvant immunotherapy combined with chemotherapy in the treatment of stage III lung squamous cell carcinoma: a retrospective cohort study",
        "10601883": "Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)",
        "10563767": "Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade",
        "10526657": "Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4+ T cells through regulating type 2 conventional dendritic cells",
        "10504845": "What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?",
        "10485299": "Neoadjuvant Versus Adjuvant Systemic Therapy for Early-Stage Non-Small Cell Lung Cancer: The Changing Landscape Due to Immunotherapy",
        "10483075": "Single-cell insights into the dynamic tumor microenvironment changes during immunotherapy of non-small cell lung cancer",
        "10466912": "Brief Report: Acetaminophen Reduces Neoadjuvant Chemoimmunotherapy Efficacy in Patients With NSCLC by Promoting Neutrophil Extracellular Trap Formation: Analysis From a Phase 2 Clinical Trial",
        "10463929": "Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol",
        "10452134": "Beyond the Frontline: A Triple-Line Approach of Thoracic Surgeons in Lung Cancer Management\u2014State of the Art",
        "10422963": "Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy",
        "10400609": "Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study",
        "10375848": "High-dose chemotherapy sensitizes locally advanced esophageal squamous cell carcinoma to PD-1 blockade for a higher pathological complete response rate and survival",
        "10339250": "Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non\u2011small cell lung cancer",
        "10318538": "Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports",
        "10260491": "Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?",
        "10236616": "Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non\u2013small\u2010cell lung cancer",
        "10213055": "PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells",
        "10129899": "A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights",
        "10091248": "\u80f8\u90e8SMARCA4\u7f3a\u5931\u6027\u672a\u5206\u5316\u80bf\u7624\u7684\u75c5\u7406\u8bca\u65ad\u4e0e\u8054\u5408\u514d\u75ab\u68c0\u6d4b\u70b9\u6291\u5236\u5242\u6cbb\u7597",
        "10052589": "Neoadjuvant immunotherapy in resectable non-small-cell lung cancer",
        "10019757": "PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)",
        "10000462": "Precision Surgery in NSCLC",
        "9992580": "Anatomic lung resection after immune checkpoint inhibitors for initially unresectable advanced-staged non-small cell lung cancer: a retrospective cohort analysis",
        "9985263": "Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing",
        "9947557": "Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer",
        "9911863": "Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel\u2013based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer",
        "9911612": "High post\u2010chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy",
        "9902866": "Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers",
        "9844511": "Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer",
        "9837269": "The IASLC grading system for invasive pulmonary adenocarcinoma: a potential prognosticator for patients receiving neoadjuvant therapy",
        "9798701": "A systematic review and meta-analysis of neoadjuvant chemoimmunotherapy in stage III non-small cell lung cancer",
        "9735901": "Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review",
        "9708573": "Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms",
        "9688539": "The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments",
        "9649922": "Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancer",
        "9646962": "Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy",
        "9637677": "Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients\u2019 overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study",
        "9594940": "Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancer",
        "9577189": "CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy",
        "9556329": "Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial",
        "9554679": "International expert consensus on immunotherapy for early-stage non-small cell lung cancer",
        "9486045": "Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors",
        "9485257": "Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis",
        "9482961": "Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma",
        "9472066": "Association of Pathologic Complete Response and Long-Term Survival Outcomes Among Patients Treated With Neoadjuvant Chemotherapy or Chemoradiotherapy for NSCLC: A Meta-Analysis",
        "9447511": "Evolution of systemic therapy for stages I\u2013III non-metastatic non-small cell lung cancer",
        "9436661": "Dynamic  18F\u2010FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non\u2010small cell lung cancer",
        "9390428": "Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design",
        "9386359": "Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study",
        "9346153": "\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u65b0\u8f85\u52a9\u514d\u75ab\u6cbb\u7597\u8fdb\u5c55",
        "9279493": "Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)",
        "9270858": "SUVmax\u2014\u0394 makes the difference",
        "9201164": "Neoadjuvant immunotherapy followed by surgery with curative intent in 35 patients with advanced NSCLC: the retrospective experiences of a multidisciplinary team",
        "9198346": "Spatial metabolomics for evaluating response to neoadjuvant therapy in non\u2010small cell lung cancer patients",
        "9179283": "Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors",
        "9178701": "Efficacy and safety of camrelizumab (a PD-1 inhibitor) combined with chemotherapy as a neoadjuvant regimen in patients with locally advanced non-small cell lung cancer",
        "9167789": "Distinct immune gene programs associated with host tumor immunity, neoadjuvant chemotherapy and chemoimmunotherapy in resectable NSCLC",
        "9153074": "Neoadjuvant treatment in non-small cell lung cancer: New perspectives with the incorporation of immunotherapy",
        "9133629": " Ex Vivo Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction In Vivo ",
        "9091013": "The histologic effects of neoadjuvant stereotactic body radiation therapy (SBRT) followed by pulmonary metastasectomy\u2014rationale and protocol design for the Post SBRT Pulmonary Metastasectomy (PSPM) trial",
        "9044000": "Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice",
        "9023831": "Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)",
        "8958675": "Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP)",
        "8895738": "Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome",
        "8885645": "The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy",
        "8853628": "Preoperative and Postoperative Systemic Therapy for Operable Non\u2013Small-Cell Lung Cancer",
        "8833612": "Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC",
        "8743523": "Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint",
        "8670334": "Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non\u2013small-cell lung cancer: a case report",
        "8641007": "Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations",
        "8628782": "Meta-Analysis of Neoadjuvant Immunotherapy for Patients with Resectable Non-Small Cell Lung Cancer",
        "8535119": "Neoadjuvant Therapy in Lung Cancer: What Is Most Important: Objective Response Rate or Major Pathological Response?",
        "8534862": "Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant Therapy",
        "8528627": "Regression Analysis of Factors Based on Cluster Analysis of Acute Radiation Pneumonia due to Radiation Therapy for Lung Cancer",
        "8512473": "Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients",
        "8512472": "Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer",
        "8414043": "Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review",
        "8393473": "Lung Cancer Surgery after Neoadjuvant Immunotherapy",
        "8391213": "Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors",
        "8366304": "Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center",
        "8350086": "A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future",
        "8288017": "Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial",
        "8264323": "Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review",
        "8264321": "Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist",
        "8246389": "\u65b0\u8f85\u52a9\u514d\u75ab\u6cbb\u7597\u8054\u5408\u5316\u7597\u5728\u53ef\u624b\u672f\u7684\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u7684\u521d\u6b65\u7597\u6548\u8bc4\u4f30",
        "8216907": "A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response",
        "8197012": "Genetic Analysis and Operative Outcomes in Patients with Oncogene-Driven Advanced NSCLC Treated with Cytoreductive Surgery as a Component of Local Consolidative Therapy",
        "8106052": "Perioperative safety and feasibility outcomes of stage IIIA-N2 non-small cell lung cancer following neoadjuvant immunotherapy or neoadjuvant chemotherapy: a retrospective study",
        "8088941": "Is major pathologic response sufficient to predict survival in resectable nonsmall\u2010cell lung cancer patients receiving neoadjuvant chemotherapy?",
        "7930417": "2020 Innovation\u2010Based Optimism for Lung Cancer Outcomes",
        "7925896": "Case Report: Transformation From Cold to Hot Tumor in a Case of NSCLC Neoadjuvant Immunochemotherapy Pseudoprogression",
        "7867758": "Neoadjuvant treatment of stage IIIA-N2 in EGFR-Mutant/ALK-rearranged non-small cell lung cancer",
        "7867746": "Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer",
        "7815365": "Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer",
        "7670953": "Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee",
        "7544973": "SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic",
        "7475553": "Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles"
    },
    "journal": "Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer",
    "topics": [
        "multidisciplinary, specimens, pathologic, recommendations",
        "specimens, assessment, cancer, pathologic",
        "lung, resection, neoadjuvant, following"
    ]
}